Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering
Science · 19.03.2026 · 391 (6791)
DOI: 10.1126/science.adx3162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 19.03.2026. Verfasst von Xiaojing Chen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Acid Phosphatase, Antigens, Neoplasm, Immune Tolerance, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Howard Hughes Medical Institute, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
T cells are often weakly responsive to tumor self-antigens because of central tolerance, constraining their ability to eliminate tumors. We exploited mechanical force to engineer a weakly reactive T cell receptor (TCR) specific for a nonmutated tumor-associated antigen (TAA), prostatic acid phosphatase (PAP). We identified a catch-bonding “hotspot” whose mutation enhanced T cell activity by increasing TCR–pMHC (peptide–major histocompatibility complex) bond lifetime while preserving physiological affinities and antigen fine specificities. T cells expressing these engineered TCRs showed vastly superior expansion in the tumor, effector phenotypes, and tumor elimination. Crystal structures and molecular dynamics simulations revealed a single amino acid mutation at the catch-bond hotspot primes the TCR for peptide interaction through water reorganization at the TCR-pMHC interface. Catch-bond engineering is a viable biophysically based strategy for transforming tolerized antitumor T cells into potent TCR–T cell therapy killers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA, USA.
- Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA.
- Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Xiaojing Chen, Zhiyuan Mao, Margherita Persechino, Kevin M Jude, Masato Ogishi, Kelvin C Mo, Xinyu Xiang, Xinbo Yang, Shiqin Liu, Aerin Yang, Matthias Obenaus, Nan Wang, Miyako Noguchi, John K Lee, Zinaida Good, Naomi R Latorraca, Brian D Evavold, Owen N Witte, K Christopher Garcia
Förderung
- Howard Hughes Medical Institute
- NCI NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- U.S. Department of Defense
- National Cancer Institute
- Mark Foundation For Cancer Research
- CRUK Lung Cancer Centre of Excellence
Zitieren
APA
Chen, X., Mao, Z., Kolawole, E. M., Persechino, M., Jude, K. M., Ogishi, M., Mo, K. C., McLaughlin, J., Cheng, D., Xiang, X., Yang, X., Gee, C., Liu, S., Yang, A., Obenaus, M., Wang, N., Noguchi, M., Stoyanova, T., Lee, J. K., …, & Garcia, K. C. (2026). Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering. Science, 391(6791). https://doi.org/10.1126/science.adx3162
Vancouver
Chen X, Mao Z, Kolawole EM, Persechino M, Jude KM, Ogishi M, et al. Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering. Science. 2026;391(6791). doi:10.1126/science.adx3162
BibTeX
@article{Chen2026,
author = {Chen, Xiaojing and Mao, Zhiyuan and Kolawole, E Motunrayo and Persechino, Margherita and Jude, Kevin M and Ogishi, Masato and Mo, Kelvin C and McLaughlin, Jami and Cheng, Donghui and Xiang, Xinyu and Yang, Xinbo and Gee, Caitlin and Liu, Shiqin and Yang, Aerin and Obenaus, Matthias and Wang, Nan and Noguchi, Miyako and Stoyanova, Tanya and Lee, John K and Good, Zinaida and Latorraca, Naomi R and Evavold, Brian D and Witte, Owen N and Garcia, K Christopher},
title = {Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering},
journal = {Science},
year = {2026},
volume = {391},
number = {6791},
doi = {10.1126/science.adx3162}
}
EUVIMED